...
首页> 外文期刊>Chemical Society Reviews >Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery
【24h】

Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery

机译:融合两全其美:药物递送中混合了脂质包裹的基质纳米复合材料

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The advent of nanotechnology has revolutionized drug delivery in terms of improving drug efficacy and safety. Both polymer-based and lipid-based drug-loaded nanocarriers have demonstrated clinical benefit to date. However, to address the multifaceted drug delivery challenges ahead and further expand the spectrum of therapeutic applications, hybrid lipid-polymer nanocomposites have been designed to merge the beneficial features of both polymeric drug delivery systems and liposomes in a single nanocarrier. This review focuses on different classes of nanohybrids characterized by a drug-loaded polymeric matrix core enclosed in a lipid shell. Various nanoengineering approaches to obtain lipid-polymer nanocomposites with a core-shell nanoarchitecture will be discussed as well as their predominant applications in drug delivery.
机译:纳米技术的出现改变了药物的输送方式,从而提高了药物的效力和安全性。迄今为止,基于聚合物和基于脂质的载有药物的纳米载体均已证明具有临床益处。然而,为了解决未来面临的多方面的药物输送挑战并进一步扩大治疗应用的范围,已经设计了混合脂质-聚合物纳米复合材料,以将聚合物药物输送系统和脂质体的有益特征合并在单个纳米载体中。这篇综述着重于不同种类的纳米杂交体,其特征是包裹在脂质壳中的载有药物的聚合物基质核心。将讨论获得具有核-壳纳米结构的脂质聚合物纳米复合材料的各种纳米工程方法,以及它们在药物递送中的主要应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号